These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19004600)

  • 1. Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.
    Halperin AC; McAfee TA; Jack LM; Catz SL; McClure JB; Deprey TM; Richards J; Zbikowski SM; Swan GE
    J Subst Abuse Treat; 2009 Jun; 36(4):428-34. PubMed ID: 19004600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness.
    Purvis TL; Mambourg SE; Balvanz TM; Magallon HE; Pham RH
    Ann Pharmacother; 2009 May; 43(5):862-7. PubMed ID: 19383936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral counseling and varenicline treatment for smoking cessation.
    Swan GE; McClure JB; Jack LM; Zbikowski SM; Javitz HS; Catz SL; Deprey M; Richards J; McAfee TA
    Am J Prev Med; 2010 May; 38(5):482-90. PubMed ID: 20409497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New drugs; varenicline].
    van Bronswijk H; Dubois EA; Zitman FG; Cohen AF
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline (Chantix) for tobacco dependence.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):66-8. PubMed ID: 16977281
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial.
    Hawk LW; Ashare RL; Lohnes SF; Schlienz NJ; Rhodes JD; Tiffany ST; Gass JC; Cummings KM; Mahoney MC
    Clin Pharmacol Ther; 2012 Feb; 91(2):172-80. PubMed ID: 22130118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
    Tonstad S
    Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
    Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
    Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline in smoking cessation.
    Tonstad S; Rollema H
    Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline for tobacco dependence.
    Hays JT; Ebbert JO
    N Engl J Med; 2008 Nov; 359(19):2018-24. PubMed ID: 18987369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varenicline for tobacco dependence: panacea or plight?
    Williams JM; Steinberg MB; Steinberg ML; Gandhi KK; Ulpe R; Foulds J
    Expert Opin Pharmacother; 2011 Aug; 12(11):1799-812. PubMed ID: 21644843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.